Side-by-side comparison of AI visibility scores, market position, and capabilities
Austin MN branded food (NYSE: HRL) ~$11.9B FY2024 revenue; SPAM/Skippy/Planters/Jennie-O portfolio, 250-position restructuring 2025, Planters $3.35B integration challenge competing with Tyson and Conagra.
Hormel Foods Corporation is an Austin, Minnesota-based multinational food company — publicly traded on the New York Stock Exchange (NYSE: HRL) as an S&P 500 Consumer Staples component — producing, marketing, and distributing branded consumer food products across refrigerated, shelf-stable, and deli categories under the Hormel, SPAM, Jennie-O, Skippy, Planters, Columbus Craft Meats, Applegate, Justin's, Natural Choice, and Wholly brands through approximately 20,000 employees serving customers across 80+ countries. In fiscal year 2024 (ending October 2024), Hormel reported revenue of approximately $11.9 billion, with performance reflecting challenges in the turkey market (Jennie-O facing supply and competitive dynamics), commodity cost management, and ongoing integration of the Planters snack nuts business (acquired from Kraft Heinz in 2021 for $3.35 billion). Hormel announced a comprehensive corporate restructuring in 2025 — including a voluntary early retirement program and the elimination of approximately 250 corporate and sales positions — targeting $20-25 million in restructuring charges as the company streamlines operations to improve efficiency and align resources with strategic priorities following the Planters acquisition integration challenge. CEO Jim Snee leads Hormel's "Transform and Modernize" strategy focusing on operational efficiency, brand investment, and portfolio optimization. The Planters acquisition (peanuts, cashews, mixed nuts, peanut butter, Cheez Balls) gave Hormel a leading position in the $8B+ US nut snack market but has required margin improvement work.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.